| Matthew Henry Oltmanns, MD | |
|
2208 University Blvd Ste 101, Birmingham, AL 35233-2313 | |
| (205) 933-2625 | |
| (205) 558-2553 |
| Full Name | Matthew Henry Oltmanns |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 2208 University Blvd Ste 101, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063603322 | NPI | - | NPPES |
| 119132 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 30080 (Alabama) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 30080 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Callahan Eye Hospital | Birmingham, AL | Hospital |
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Specialists Of Alabama In Montgomery Llc | 1759314495 | 4 |
| Retina Specialists Of Alabama Llc | 7416930425 | 6 |
| Retina Specialists Of West Alabama Llc | 9133128507 | 3 |
News Archive
On behalf of its Medical Imaging Sector, MEDEC, Canada's Medical Technology Companies, is calling on the Ontario government to develop a comprehensive strategy for the deployment of Positron Emission Tomography (PET) Scanning technology across the Province.
Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.
Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.
Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.
› Verified 6 days ago
| Entity Name | Retina Specialists Of Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437194867 PECOS PAC ID: 7416930425 Enrollment ID: O20040610001122 |
News Archive
On behalf of its Medical Imaging Sector, MEDEC, Canada's Medical Technology Companies, is calling on the Ontario government to develop a comprehensive strategy for the deployment of Positron Emission Tomography (PET) Scanning technology across the Province.
Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.
Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.
Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.
› Verified 6 days ago
| Entity Name | Retina Specialists Of Alabama In Montgomery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851336226 PECOS PAC ID: 1759314495 Enrollment ID: O20050914000285 |
News Archive
On behalf of its Medical Imaging Sector, MEDEC, Canada's Medical Technology Companies, is calling on the Ontario government to develop a comprehensive strategy for the deployment of Positron Emission Tomography (PET) Scanning technology across the Province.
Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.
Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.
Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.
› Verified 6 days ago
| Entity Name | Retina Specialists Of West Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528150851 PECOS PAC ID: 9133128507 Enrollment ID: O20061212000563 |
News Archive
On behalf of its Medical Imaging Sector, MEDEC, Canada's Medical Technology Companies, is calling on the Ontario government to develop a comprehensive strategy for the deployment of Positron Emission Tomography (PET) Scanning technology across the Province.
Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.
Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.
Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Henry Oltmanns, MD 2101 Highland Ave S Ste 350, Birmingham, AL 35205-4009 Ph: (205) 933-2625 | Matthew Henry Oltmanns, MD 2208 University Blvd Ste 101, Birmingham, AL 35233-2313 Ph: (205) 933-2625 |
News Archive
On behalf of its Medical Imaging Sector, MEDEC, Canada's Medical Technology Companies, is calling on the Ontario government to develop a comprehensive strategy for the deployment of Positron Emission Tomography (PET) Scanning technology across the Province.
Husbands or wives who care for spouses with dementia are six times more likely to develop the memory-impairing condition than those whose spouses don't have it, according to results of a 12-year study led by Johns Hopkins, Utah State University, and Duke University.
Many women at high risk for breast cancer are foregoing tamoxifen, the first FDA-approved drug for prevention of breast cancer, due to concerns about side effects, increased risk of other cancers, and lack of information, a new study by researchers in Boston shows. The study was published in the December 14 in the Journal of Clinical Oncology.
Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients.
› Verified 6 days ago
Carol E Rosenstiel, OD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 200, Birmingham, AL 35233 Phone: 205-325-8620 | |
Alex J Wright, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 205-325-8100 Fax: 205-325-8547 | |
Elmar M Lawaczeck, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1009 Montgomery Hwy, Suite 200, Birmingham, AL 35216 Phone: 205-397-9400 Fax: 205-397-9455 | |
Harold Augustus Helms, MD, PHD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 23rd St S, Ste 100, Birmingham, AL 35205 Phone: 205-933-2020 Fax: 205-933-0908 | |
Krupa Hasmukh Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-325-8620 | |
William Charles Gambla, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-996-8660 |